Seeking Alpha

Progenics Pharmaceuticals EPS in-line, misses on revenues

  • Progenics Pharmaceuticals (PGNX): Q2 EPS of -$0.24 in-line.
  • Revenue of $1.80M misses by $0.06M. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs